← Back to Search

Behavioural Intervention

CHW Initiatives for Type 2 Diabetes

N/A
Recruiting
Led By Elizabeth Vaughan, DO
Research Sponsored by The University of Texas Medical Branch, Galveston
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Must not have
Not Spanish-speaking
Type 1 diabetes diagnosis
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-months
Awards & highlights
No Placebo-Only Group

Summary

This trial will help Latino church members become CHWs to improve diabetes care, tracking outcomes with an online platform to reduce healthcare access and quality barriers.

Who is the study for?
This trial is for Spanish-speaking Latino adults with Type 2 Diabetes. It's not suitable for those who are pregnant, planning to be pregnant soon, have Type 1 diabetes, or have certain mental health conditions like schizophrenia or severe Alzheimer's disease.
What is being tested?
The study aims to train church members as Community Health Workers (CHWs) and use an online platform to improve healthcare access and quality for Latinos with diabetes. The effectiveness of this community-based diabetes program will be evaluated.
What are the potential side effects?
Since the intervention involves a training program rather than a medical treatment, traditional side effects are not applicable. However, participants may experience stress or time constraints due to participation in the training.

Eligibility Criteria

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not speak Spanish.
Select...
I have been diagnosed with Type 1 diabetes.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Evaluate the integration of the intervention
Secondary study objectives
Provide acceptability data of the intervention
Test the limited efficacy of the intervention

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

1Treatment groups
Experimental Treatment
Group I: Diabetes program and educationExperimental Treatment1 Intervention
Receive diabetes program and education

Find a Location

Who is running the clinical trial?

University of HoustonOTHER
151 Previous Clinical Trials
47,533 Total Patients Enrolled
The University of Texas Medical Branch, GalvestonLead Sponsor
254 Previous Clinical Trials
57,316 Total Patients Enrolled
6 Trials studying Diabetes
449 Patients Enrolled for Diabetes
Baylor College of MedicineOTHER
1,028 Previous Clinical Trials
6,029,762 Total Patients Enrolled
9 Trials studying Diabetes
881 Patients Enrolled for Diabetes
Elizabeth Vaughan, DOPrincipal InvestigatorUniversity of Texas Medical Branch, Galveston
2 Previous Clinical Trials
585 Total Patients Enrolled

Media Library

Diabetes Program (Behavioural Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05965869 — N/A
Diabetes Research Study Groups: Diabetes program and education
Diabetes Clinical Trial 2023: Diabetes Program Highlights & Side Effects. Trial Name: NCT05965869 — N/A
Diabetes Program (Behavioural Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05965869 — N/A
~122 spots leftby Jul 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top